Topic search: LEGAL

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

Pharmacy Legal Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2025 Pg. 267-278	Legal Challenges to Compounding Drugs for Weight Loss Author(s): Combs Blinn E, Howard Brad
May/Jun 2025 Pg. 182-189	One Decade In and Counting: How 503B Outsourcing Facilities Are Finding Their Place in the Industry Author(s): Alexander Michael R, Combs Blinn E, Howard Brad
Mar/Apr 2025 Pg. 96-103	Current Problems of Pharmaceutical Compounding in Hungary Author(s): Dobson Szabolcs
Mar/Apr 2025 Pg. 104-110	Advertising and Marketing for Compounding Pharmacies: Many Shades of Grey Author(s): Hobbs Amanda F, Howard Brad
Jan/Feb 2025 Pg. 6-13	Navigating the Direct Importation of Active Pharmaceutical Ingredients: Compliance Considerations for Compounding Pharmacies Author(s): Byars Bradley S, Howard Brad
Jan/Feb 2025 Pg. 22-27	Best Practices When Compounding FDA-Approved Drugs Listed in Shortage Author(s): Alliance for Pharmacy Compounding
Jan/Feb 2025 Pg. 33-36	Compounded GLP-1 Drugs and Patient Adverse Events Author(s): Alliance for Pharmacy Compounding
Sep/Oct 2024 Pg. 374-375	Standard Operating Procedure for Assignment of Beyond-Use Dates Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 450-453	Drug Utilization Review: Our Patients Deserve Our Very Best Author(s): Jackson Kathleen
Nov/Dec 2023 Pg. 461-466	Considerations in Qualifying Critical Suppliers Author(s): Summers Amy
Nov/Dec 2023 Pg. 474-481	Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 180	PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again! Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 208-210	Show Me the Science: A Perspective Author(s): Grzib Anthony
May/Jun 2023 Pg. 211-217	Quality Assurance: Compounding Record Audits for Error Prevention Author(s): Hawkins Jessica
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Sep/Oct 2022 Pg. 396-398	The FDA is in a Hole. It Should Stop Digging. Author(s): Brunner Scott
Jul/Aug 2022 Pg. 309-315	Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Author(s): Summers Amy
May/Jun 2022 Pg. 180	PreScription: Standing in the Gap Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 182-186	Art of Pharmacy v. State Author(s): Standridge Rob
May/Jun 2022 Pg. 201-209	Compounding for Investigational and Clinical Studies Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 211-213	Three Things You Need to Know Right Now Author(s): Brunner Scott
Mar/Apr 2022 Pg. 92	PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 100-109	Allowing Compounding Pharmacies to Address Drug Shortages Author(s): Broughel James
Jan/Feb 2022 Pg. 30-32	Everything Old is New Again Author(s): Brunner Scott
Sep/Oct 2021 Pg. 356	PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Sep/Oct 2021 Pg. 364-371	Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Sep/Oct 2021 Pg. 378-384	Realities of Pharmaceutical Compounding in the Republic of Uzbekistan Author(s): Umarov Ulugbek, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar
Sep/Oct 2021 Pg. 386-387	It's Time for a New Philosophy Author(s): Brunner Scott
Sep/Oct 2021 Pg. 389-395	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jul/Aug 2021 Pg. 276-281	Expecting the Expected: Planning Considerations for Cleanroom Construction Author(s): Roberts Patricia A, Kroon Laura
Jul/Aug 2021 Pg. 288-295	Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Jul/Aug 2021 Pg. 296-297	A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Author(s): Brunner Scott
Jul/Aug 2021 Pg. 298-302	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
May/Jun 2021 Pg. 206-209	FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Author(s): Brunner Scott
Mar/Apr 2021 Pg. 92	PreScription: The Past (-->2020), The Present, and The Future (2021-->) Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 14-17	Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2 Author(s): DeRosa Angela
Jan/Feb 2021 Pg. 18-23	Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Author(s): McKettrick Greg, Yoch Doug
Jan/Feb 2021 Pg. 24-28	Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Author(s): McElhiney Linda F
Jan/Feb 2021 Pg. 62-72	Formulation and Pharmaceutical Evaluation of Extemporaneous α-arbutin Creams for the Treatment of Melasma Author(s): Teeranachaideekul Veerawat, Boonsongsawat Worrawee, Asanawittaya Waralee, Jintapattanakit Anchalee, Chantasart Doungdaw, Wongrakpanich Amaraporn
Nov/Dec 2020 Pg. 444	PreScription: The NASEM cBHT Report, Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 446-448	NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 451-458	Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Nov/Dec 2020 Pg. 466-470	Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 Author(s): DeRosa Angela
Sep/Oct 2020 Pg. 356	Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2020 Pg. 386-387	An Unconscionable, Unnecessary Fight Author(s): Brunner Scott
Jul/Aug 2020 Pg. 268	PreScription: COVID-19 and Compounding Pharmacists Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 270-276	Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Jul/Aug 2020 Pg. 296-297	Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Author(s): Brunner Scott
Jul/Aug 2020 Pg. 322-326	Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula Author(s): Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
May/Jun 2020 Pg. 198-199	U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk Author(s): Brunner Scott
Mar/Apr 2020 Pg. 92	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 110-113	A "North Star" for Pharmacy Compounders Author(s): Brunner Scott
Jan/Feb 2020 Pg. 4	PreScription: One Size Does Not Fit All! Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 14-19	How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Author(s): Vaughn Stacey R, Radwick Allison
Jan/Feb 2020 Pg. 21-27	Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Author(s): Cabaleiro Joe
Jan/Feb 2020 Pg. 28-29	New and Improved! Author(s): Brunner Scott
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Nov/Dec 2019 Pg. 444	PreScription: As Things Change…. Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 454-461	How to Qualify Container Closure Systems for Intended Use, Part 1 Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019 Pg. 462-464	Are You Part of the Solution or Part of the Problem? Author(s): Brunner Scott
Sep/Oct 2019 Pg. 356	PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 383-385	Threading the Needle Author(s): Brunner Scott
Jul/Aug 2019 Pg. 294-296	Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future Author(s): Brunner Scott
May/Jun 2019 Pg. 182-186	How to Develop and Maintain a Hazardous Drug List Author(s): Dillon L Rad
May/Jun 2019 Pg. 208-209	Can We Fix It? Author(s): Brunner Scott
Mar/Apr 2019 Pg. 92	PreScription: Compounding with Cannabidiol Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 106-111	Nimodipine Compounded Oral Suspension: A True Documented Medical Need Author(s): McElhiney Linda F
Mar/Apr 2019 Pg. 120-121	Patient Access Is a Patient Safety Issue Author(s): Pore David
Mar/Apr 2019 Pg. 135-143	Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 6-12	An Outlook on the European and Italian Rules to Guarantee Magistral Formulas Author(s): Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
Jan/Feb 2019 Pg. 32-33	U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 47-49	Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Author(s): Martin Matt
Nov/Dec 2018 Pg. 475-478	Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Author(s): Martin Matt
Sep/Oct 2018 Pg. 356	PreScription: Updating Formulations Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
Sep/Oct 2018 Pg. 369-384	Certification of Powder-containment Hoods for Nonsterile Compounding Author(s): Mulder Kyle, Dozzi Raphael
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2018 Pg. 401-404	Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Author(s): Martin Matt
May/Jun 2018 Pg. 204-205	Your Presence is Needed at Compounders on Capitol Hill! Author(s): Blankenship Cynthia
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018 Pg. 125-126	IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Author(s): Blankenship Cynthia
Mar/Apr 2018 Pg. 129-134	Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Author(s): Rhoads Rick
Jan/Feb 2018 Pg. 4	PreScription: 2017--Some Good Things Happened and Some Others Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 7-16	Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018 Pg. 26-28	The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Author(s): Blankenship Cynthia
Nov/Dec 2017 Pg. 444	PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 468	Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! Author(s): Blankenship Cynthia
Nov/Dec 2017 Pg. 513-517	Validation of the Technological Process of the Preparation "Milk by Vidal" Author(s): Savchenko LP, Mishchenko VA, Georgiyants VA
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 364-370	Child-safety Containers/Devices and Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 373-380	Documentation: Records and Reports Author(s): Akers Michael J
Sep/Oct 2017 Pg. 382-383	IACP Legislative/Regulatory Update Author(s): International Academy of Compounding Pharmacists
Jul/Aug 2017 Pg. 290-291	The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 Author(s): Rice Baylor
May/Jun 2017 Pg. 180	PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 212-213	International Academy of Compounding Pharmacists Legislative/Regulatory Update Author(s): Rice Baylor
Mar/Apr 2017 Pg. 92	PreScription: Whatever Happened to Common Sense? Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Mar/Apr 2017 Pg. 116-117	The International Academy of Compounding Pharmacists Introduces a New President Author(s): Rice Baylor
Mar/Apr 2017 Pg. 118-124	Quality Control: (Material) Safety Data Sheets Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 127-130	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 4	PreScription: Compounding Pharmacy Issues for 2017 Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 19-21	When to Compound Medications for Veterinary Patients Author(s): Forsythe Lauren Eichstadt
Jan/Feb 2017 Pg. 28	Why You Should Become an International Academy of Compounding Pharmacists Member Author(s): Gates Ernest P Jr
Nov/Dec 2016 Pg. 457-458	U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Author(s):
Nov/Dec 2016 Pg. 477-479	The "Lists": What Do They Mean? Author(s): Voliva John
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 356	PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Sep/Oct 2016 Pg. 377-378	More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! Author(s): Voliva John
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
Jul/Aug 2016 Pg. 294-296	IACP's 2016 Compounders on Capitol Hill Asks Author(s):
Jul/Aug 2016 Pg. 307-314	Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Author(s): Akers Michael J
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 180	PreScription: Patient Access to Pharmaceuticals Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 189-192	Compounding in Nigeria Author(s): Alfred-Ugbenbo Deghinmotei, Zdoryk Oleksandr A, Georgiyants Victoriya A, Schnatz Rick
May/Jun 2016 Pg. 194	IACP Names Voliva Executive Vice President Author(s): McCrory Gary
Mar/Apr 2016 Pg. 92	PreScription: Compounding: A Changing Paradigm Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 95-96	Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Author(s): McCrory Gary
Jan/Feb 2016 Pg. 13-18	Microbial Identification in Pharmaceutical Compounding Author(s): Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
Jan/Feb 2016 Pg. 29-36	Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Author(s): Pritchett Jon, Mixon William, O'Connell Kevin
Jan/Feb 2016 Pg. 86-87	PostScription: The Home Field Advantage Author(s): Cabaleiro Joe
Nov/Dec 2015 Pg. 442	PreScription: The Documented Past and the Exciting Future Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 449-450	International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Author(s): Miller David G
Nov/Dec 2015 Pg. 453-463	Applying Quality of Design Concepts to Pharmacy Compounding Author(s): Timko Robert J
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 375	The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Author(s): Miller David G
Sep/Oct 2015 Pg. 377-380	The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015 Pg. 389-390	Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 437	PostScription: Progress Report: Provider Status Continues to Gain Strength! Author(s): Menighan Thomas E
Jul/Aug 2015 Pg. 266	PreScription: Potpourri of Opinions…From Many Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Jul/Aug 2015 Pg. 311-313	Basics of Compounding: The "Negative" List Author(s): Allen Loyd V
May/Jun 2015 Pg. 212	IACP Says: "Fix DQSA" Author(s): Miller David
May/Jun 2015 Pg. 215-221	Quality Assurance and Quality Control, Part 2 Author(s): Akers Michael J
May/Jun 2015 Pg. 271	PostScription: Opportunities to Change the Pharmacy Landscape Author(s): Menighan Thomas E
Mar/Apr 2015 Pg. 94-102	New England Compounding Center Indictment Author(s): Cabaleiro Joe
Mar/Apr 2015 Pg. 104-106	Standing Together Fixing the Drug Quality and Security Act Author(s): Miller David G
Mar/Apr 2015 Pg. 109-112	Standarized Compounding: The Importance of Doing it the Same Way Every Time Author(s): Dillon L Rad
Jan/Feb 2015 Pg. 4	PreScription: 2014 in Review Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 30-37	Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance Author(s): Grilli Anthony, Sutton Scott
Jan/Feb 2015 Pg. 49-56	Basics of Sterile Compounding: Aseptic Processing Author(s): Akers Michael J
Jan/Feb 2015 Pg. 57-58	Basics of Compounding: The Revised "Not to Compound List" Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 86-87	PostScription: Pharmacists Advancing Toward Provider Status Author(s): Menighan Thomas E
Nov/Dec 2014 Pg. 470-472	Compounding Legislation: Focus Shifts to States Author(s): Miller David G
Nov/Dec 2014 Pg. 526-527	PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future Author(s): Cabaleiro Joe
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
Sep/Oct 2014 Pg. 392-395	Compounding Practices in a Portuguese Community Pharmacy Author(s): Reis Maria, Carvalho Maria, Rodrigues Angelo
Sep/Oct 2014 Pg. 438-439	PostScription: The Future of Veterinary Compounding Author(s): Jordan Dinah G
Jul/Aug 2014 Pg. 268	PreScription: Challenging Times Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 270-276	Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Author(s): Johnson Kain, Sully Andrew, Anthenat Bruce
Jul/Aug 2014 Pg. 293-300	Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Author(s): Kumar Anuj, Madan Anil K
Jul/Aug 2014 Pg. 302	400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill Author(s): Miller David G
Jul/Aug 2014 Pg. 305-310	Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
May/Jun 2014 Pg. 180	PreScription: Déjà Vu All Over Again Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 208	The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Author(s): Miller David G
Mar/Apr 2014 Pg. 92	PreScription: Standards vs Opinions Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 101-111	Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Author(s): Timko Robert J, Crooker Philip EM
Mar/Apr 2014 Pg. 112-116	Compounding Practices in Iran Author(s): Goodarzi Navid, Niknam Somayeh, Akbarzadeh Tahmineh, Gholami Kheirollah
Mar/Apr 2014 Pg. 117-118	IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Author(s): Miller David G
Jan/Feb 2014 Pg. 4	PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 20-29	Good Enough for America Author(s): Worthen Dennis B
Jan/Feb 2014 Pg. 35-36	U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Author(s): Miller David G
Nov/Dec 2013 Pg. 477-479	Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 480-481	HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now? Author(s): Miller David G
Nov/Dec 2013 Pg. 485-489	Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety Author(s): Prince Bryan, Lundeval Jeremy
Sep/Oct 2013 Pg. 356	PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 358-362	Compounding Pharmacies: Before and After an Inspection Author(s): Kulkarni Darshan, Ricketts Samantha
Sep/Oct 2013 Pg. 364-368	Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 375-378	2013 State Compounding Legislation Tracker Updated: August 12, 2013 Author(s): Miller David G
Sep/Oct 2013 Pg. 439	PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 283-288	United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Author(s): Newton David W
Jul/Aug 2013 Pg. 290-293	Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover Author(s): Rizo Mike
Jul/Aug 2013 Pg. 302-304	International Academy of Compounding Pharmacists Legislative/Regulatory Update Author(s): Miller David G
Jul/Aug 2013 Pg. 351	PostScription: Traditional vs Nontraditional Pharmacy Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 180	PreScription: Compounding for Drug Shortages Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 182-190	Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Author(s): Mixon Bill, Nain John
May/Jun 2013 Pg. 193-199	Decontamination Technology: The Missing Element Author(s): Rahe Hank
May/Jun 2013 Pg. 206	International Academy of Compounding Pharmacists' Legislative/Regulatory Update Author(s): Miller David G
May/Jun 2013 Pg. 210-219	Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 238-246	Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Mar/Apr 2013 Pg. 92	PreScription: Pharmacy Committees Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 124-127	Compounding in Ukraine Author(s): Zdoryk Oleksandr A, Georgiyants Victoriya A, Gryzodub Oleksandr I, Schnatz Rick
Mar/Apr 2013 Pg. 128	International Academy of Compounding Pharmacists Legislative/Regulatory Update Author(s): Miller David G
Jan/Feb 2013 Pg. 4	PreScription: Looking for Solutions Author(s): Menighan Thomas E
Jan/Feb 2013 Pg. 6-8	Pediatric Health Care: An Introduction Author(s): Williams LaVonn A
Jan/Feb 2013 Pg. 48-49	International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives Author(s): Miller David G
Jan/Feb 2013 Pg. 87	PostScription: GMPs and GCPs: A Topical Comparison Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David
Nov/Dec 2012 Pg. 456-460	Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Author(s): Lyon Joanna
Nov/Dec 2012 Pg. 476-478	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Nov/Dec 2012 Pg. 486-488	Quality Control: Analytical Methods. Certificates of Analysis, Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 490-496	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Jul/Aug 2012 Pg. 294-298	Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Author(s): Allen Loyd V Jr, Williams LaVonn A
Jul/Aug 2012 Pg. 300-302 View Sample	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Jul/Aug 2012 Pg. 304-309	Selection of Color Additives: A Regulatory View Author(s): Kumar Anuj, Dureja Harish, Madan Anil K
May/Jun 2012 Pg. 180	PreScription: You're On Your Own Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 180	PreScription: Working in Handcuffs Author(s): Menighan Thomas E
May/Jun 2012 Pg. 220-222 View Sample	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
May/Jun 2012 Pg. 230-234	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 94-96 View Sample	The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Author(s): Miller David G
Mar/Apr 2012 Pg. 98-102	Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes Author(s): Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, do Carmo Garcez Maria
Jan/Feb 2012 Pg. 86-87	PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Author(s): Cabaleiro Joe
Jan/Feb 2012 Pg. 50-52 View Sample	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Nov/Dec 2011 Pg. 444	PreScription: Compounding: Keeping Elephants Our of Our Mouseholes Author(s): Menighan Thomas E
Nov/Dec 2011 Pg. 471-472 View Sample	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Nov/Dec 2011 Pg. 474-479 View Sample	The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire Author(s): Miller David G
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Sep/Oct 2011 Pg. 356	PreScription: Third-party Inequities and Discrimination Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 368-371	Natural Tragedies: Planning for Disasters and Emergencies Author(s): Williams LaVonn A
Sep/Oct 2011 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David
Sep/Oct 2011 Pg. 408-414	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 278-284	Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy Author(s): Mixon William, Wood Adam P, Low Jennifer, Homan Linda
Jul/Aug 2011 Pg. 286-288	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David
May/Jun 2011 Pg. 180	PreScription: Greed Does Not Pay! Makena, Lucentis, and Others Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 180	PreScription: Making Things Right--Or Not? Author(s): Menighan Thomas E
May/Jun 2011 Pg. 218-221	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David
May/Jun 2011 Pg. 224-232	Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Author(s): Schnatz Rick, Hernandex-Cardoso Antonio
Mar/Apr 2011 Pg. 92	PreScription: Discontinued Drugs and Drug Shortages Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 448	PreScription: Compounding with Manufactured Products Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 450-455	Home Infusion: Overcoming the Barriers to Entry Author(s): Franklin David M
Sep/Oct 2010 Pg. 358	PreScription: Compounding Veterinary Products: Needed but Problematic Author(s): Menighan Thomas E
Sep/Oct 2010 Pg. 360-364	Home Infusion Accreditation: Another Quality Recognition Branding Tool Author(s): Canally Sandra C
Jul/Aug 2010 Pg. 268	PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 268	PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Author(s): Menighan Thomas E
May/Jun 2010 Pg. 180	PreScription: Healthcare Reform Is Not All That Is Happening in Washington Author(s): Menighan Thomas E
May/Jun 2010 Pg. 262-263	PostScription: Healthcare Reform and Compounding Issues Author(s): Levesque Paul T
Mar/Apr 2010 Pg. 131-133	Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs Author(s): Burke John, Hill Jeff
Mar/Apr 2010 Pg. 174-175	PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? Author(s): Allen Loyd V Jr, Burger Mark
Nov/Dec 2009 Pg. 532-536	Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust Author(s): Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
Nov/Dec 2009 Pg. 525-530	An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding Author(s): McElhiney Linda F
Sep/Oct 2009 Pg. 400-403	Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Author(s): Gilbert John A
Sep/Oct 2009 Pg. 447	PostScription: Setting up a National System of Compounding Pharmacies: An Introduction Author(s): Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
Jul/Aug 2009 Pg. 350-351	PostScription: Compounding Pharmacy in Puerto Rico Author(s): Lopez Marisol
Mar/Apr 2009 Pg. 92	PreScription: Electronic Prescribing Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 175	PostScription: Compounding in Argentina Author(s): Naddeo Aldo Mario
Jan/Feb 2009 Pg. 4	PreScription: A New Start: What Will 2009 Bring? Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 87-88	PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective Author(s): Guedes de Souza Hugo, do Carmo Garcez Maria, Pinheiro Vanessa A
Jan/Feb 2009 Pg. 56-62	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2009 Pg. 81-86	The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials Author(s): Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre
Sep/Oct 2008 Pg. 405-409	Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information Author(s): Neal Amy S, DeVeau Ian, Schnatz Rick G
Sep/Oct 2008 Pg. 410-413	Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship Author(s): Kirk Loren Madden
Sep/Oct 2008 Pg. 414-418	Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2008 Pg. 420-424	Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? Author(s): Baker Kenneth R
Nov/Dec 2008 Pg. 474	Prescription: Is "Globalization" a Good Idea? Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 508-513	Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Nov/Dec 2008 Pg. 514-523	Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where Author(s): Baker Kenneth R
Nov/Dec 2008 Pg. 565	PostScription: Supporting Compounding Around the World Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 284	PreScription: First Estriol, Then What? Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008 Pg. 375	PostScription: It Is Not Just What You Say…But How You Say It! Author(s): Reed-Kane Dana
Jul/Aug 2008 Pg. 286-292	Estriol: Women's Choice vs. A Manufacturer's Greed Author(s): Goodrum Jennifer
Jul/Aug 2008 Pg. 329-333	Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Jul/Aug 2008 Pg. 334-337	Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization Author(s): Westrick Salisa C, Felkey Bill G
May/Jun 2008 Pg. 180	PreScription: Pain! Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 238-241	Litigating the Legality of Compounding: The Medical Center Pharmacy Case Author(s): Gibbs Jeffrey N
Mar/Apr 2008 Pg. 94-99	Current Compounding Practices in Europe Author(s): Carvalho Maria, Tuleu Catherine, Taylor Kevin MG
Mar/Apr 2008 Pg. 102-115	Compounding Around the World Author(s): Vail Jane
Mar/Apr 2008 Pg. 116-120	Establishing a Quality-Assurance Program for Hospital Compounding Author(s): McElhiney Linda F
Mar/Apr 2008 Pg. 122-127	Hormone Therapy: It's Time for a Second Opinion Author(s): Collins Joseph J, Ahlgrimm Maria
Mar/Apr 2008 Pg. 174-175	PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care Author(s): Murry Tom
Jan/Feb 2008 Pg. 4	PreScription: Year Number 12…And Still Much Work to Do Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 38-47 View Sample	Disposing of Expired Drugs and Chemicals: New Options for Compounders Author(s): Vail Jane
Jan/Feb 2008 Pg. 63	Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 54-60	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2008 Pg. 74-82	Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
Nov/Dec 2007 Pg. 450-470	Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Author(s): Peters Gregory F, McKeon Marghi R, Nerbun Richard G
Nov/Dec 2007 Pg. 487-490	Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds Author(s): Trusley Craig
Sep/Oct 2007 Pg. 438-439	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 266	PreScription: Bias, NAMS, and HRT Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 269-272	Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature Author(s): Paoletti Jim, Kaul Monica, Kloesel Lawson G
Jul/Aug 2007 Pg. 282-286	Premarin: The Intriguing History of a Controversial Drug Author(s): Vance Dwight A
Jul/Aug 2007 Pg. 278-281	The Politics of Hormone Replacement Therapy Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 306-311	Quality-control Analytical Methods: Logbooks and Documentation Forms Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 314-323	Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007 Pg. 326-327	Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Author(s): Kupiec Tom, Kemp Jesse
Jul/Aug 2007 Pg. 338-346	Statistical Analysis of Barrier Isolator/Glovebox Glove Failure Author(s): Park Young H, Pines E, Ofouku M, Cournoyer ME
Jul/Aug 2007 Pg. 350-351	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007 Pg. 230-236	Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2007 Pg. 240-241	Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 262-263	PostScription: Lobbying: How It Affects Compounding Author(s): Rock Jim
May/Jun 2007 Pg. 178	PreScription: State or Federal Control of Pharmacy Practice Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 92	PreScription: Putting the Science Back into Pharmacy Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 113-115	Certified Diabetes Educator: A Credential for Compounding Pharmacists Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 138-143	Records and Record-Keeping for the Hospital Compounding Pharmacist Author(s): McElhiney Linda F
Jan/Feb 2007 Pg. 2	PreScription: IJPC: The Next 10 Years Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007 Pg. 56-58	Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Author(s): Anderson Derick
Jan/Feb 2007 Pg. 59-65	Pharmacogenomics: The End of Trial-and-Error Medicine? Author(s): Vail Jane
Nov/Dec 2006 Pg. 479-480	PostScription: Challenges Facing an Analytical Laboratory Author(s): Kupiec Thomas C
Nov/Dec 2006 Pg. 462-468	Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
Nov/Dec 2006 Pg. 446-448	Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 324-328	Topical Cidofovir for Treatment of Resistant Viral Infections Author(s): McElhiney Linda F
Sep/Oct 2006 Pg. 361-368	Education, Training, and Evaluation of Hospital Compounding Personnel Author(s): McElhiney Linda F
Sep/Oct 2006 Pg. 377-379	Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 162	PreScription: Standards, Legal Standards, and Accreditation Author(s):
May/Jun 2006 Pg. 165-171	Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Author(s): Reed-Kane Dana, Kirshbaum Karen
May/Jun 2006 Pg. 175-183	The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M
May/Jun 2006 Pg. 202-204	Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Author(s): Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006 Pg. 208-211	Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Author(s): Wagner James T
May/Jun 2006 Pg. 240	PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! Author(s): Mason Dave
Mar/Apr 2006 Pg. 82	PreScription: The Squeaky Wheel Gets the Grease! Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 113-119	Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Author(s): Jeffrey Megan
Jan/Feb 2006 Pg. 20-28	Pharmaceutical Legislation: An Historical Perspective Author(s): Worthen Dennis B
Jan/Feb 2006 Pg. 32-34	Pharmacy Compounding Urban Legends Author(s): Kastango Eric S
Nov/Dec 2005 Pg. 410	Prescription: Pediatric Formulation Initiatives Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 332-333	Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America Author(s): Reed-Kane Dana
Sep/Oct 2005 Pg. 364-367	Compounding: A Well-established Practice in 1938 Author(s): Houck Larry K
Jul/Aug 2005 Pg. 293-298	Local Ventilation for Safe Containment in the Pharmaceutical Industry Author(s): Walters Douglas B, Ryan Ray
Jul/Aug 2005 Pg. 284-290	Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Author(s): Wagner James T
May/Jun 2005 Pg. 209-211	Survey of State Veterinary Compounding Laws and Regulations Author(s): Goodrum Jennifer
May/Jun 2005 Pg. 247-248	PostScription: AVMA's Position on Compounding for Animals Author(s): Riddell M Gatz
Mar/Apr 2005 Pg. 93-94	Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer Author(s): Reed-Kane Dana
Mar/Apr 2005 Pg. 145	Standard Operating Procedure: SOP Master Book--Maintenance Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 127-130	Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Newton David W
Mar/Apr 2005 Pg. 136-138	Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations Author(s): Kupiec Thomas C
Mar/Apr 2005 Pg. 167	PostScription: Experts Everywhere Author(s): Rahe Hank
Jan/Feb 2005 Pg. 44-46	The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Author(s): Allen Loyd V Jr, Ashworth Lisa D
Nov/Dec 2004 Pg. 449-450	Is Veterinary Compounding Illegal Under Federal Law? Author(s): Gibbs Jeffrey N
Sep/Oct 2004 Pg. 407	PostScription: Your voice is important to the future of pharmacy Author(s): Tosh Erik
Jul/Aug 2004 Pg. 251-263	A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Author(s): Newton David W, Trissel Lawrence A
Mar/Apr 2004 Pg. 160	PostScription: Cleanroom Standards Author(s): Fitzpatrick Mike, Goldstein Ken
Jan/Feb 2004 Pg. 79-80	PostScription: The Wedgewood Case: What It Means for Pharmacies Author(s): Gibbs Jeffrey N, Wasserstein Jeffrey N
Nov/Dec 2003 Pg. 418	PreScription: Take Care with Terminology for Altered- and Slow-release Formulations Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 495	PostScription: Changing Pharmacy Regulations Could Affect US Compounders Author(s): Downing Pat, Roberson Kim
Sep/Oct 2003 Pg. 361-363 View Sample	Application of USP-NF Standards to Pharmacy Compounding Author(s): Bormel Gail, Valentine Joseph G, Williams Roger L
Jul/Aug 2003 Pg. 277-279	HIPAA Privacy and Security for Providers: The Basics Author(s): Kuruc Jullian H
Jul/Aug 2003 Pg. 281-285	Containment of Hazardous Particulates in the Compounding Pharmacy Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 320	Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics? Author(s): McElhiney Linda F
Mar/Apr 2003 Pg. 88-92	Legal & Ethical Issues for Pharmacy Websites Author(s): King LD, Brashares Jennifer
Nov/Dec 2002 Pg. 434-437	Regulatory and Operational Issues of Founding a Compounding Pharmacy Author(s): Smith Lisa K
Nov/Dec 2002 Pg. 441-442	Medications Discontinued in the United States Author(s): Ashworth Lisa D
Jul/Aug 2002 Pg. 263-266	Compounding and the Courts Author(s): Gibbs Jeffrey N, Wasserstein Jeffrey N
Jul/Aug 2002 Pg. 267-270	Facilities and Procedures for Compounding Hazardous Drugs Author(s): Rahe Hank
Jul/Aug 2002 Pg. 271-273	Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Author(s): Kramer Mark A, Grilley Bambi J
Jul/Aug 2002 Pg. 274-275	Legal Issues: Technicians in the Compounding Pharmacy Practice Author(s): Fix Jennifer Taylor
Jul/Aug 2002 Pg. 286-287	Medications Discontinued in the United States Author(s): Ashworth Lisa D
May/Jun 2002 Pg. 193	Medications Discontinued in the United States Author(s): Ashworth Lisa D
Mar/Apr 2002 Pg. 123	Medications Discontinued in the United States Author(s): Ashworth Lisa D
Mar/Apr 2002 Pg. 149-150	Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory Author(s): Ashworth Lisa D, Gordon Dana, Leiter Charles W, Snow Whit
Jan/Feb 2002 Pg. 8-10	Compounding with Controlled Substances Author(s): Whalen Mary Kate
Jan/Feb 2002 Pg. 11-12	The Problem of Drug Diversion Author(s): Burke John J
Jan/Feb 2002 Pg. 13-15	Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective Author(s): Vail Jane
Jan/Feb 2002 Pg. 80	PostScription: Regulatory Uncertainty Requires Professional Responsibility Author(s): King LD
Jul/Aug 2001 Pg. 273-274	Compounding Issues and Accreditation Agencies Author(s): Petroff Barb
May/Jun 2001 Pg. 216-217	The American Veterinary Medical Association Compounding Position Statement Author(s): Davidson Gigi S
May/Jun 2001 Pg. 226-227	Establishing and Maintaining a Compounding Pharmacy Reference Library Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 97-100	Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Author(s): Chan Debora Schotik
Mar/Apr 2001 Pg. 101-103	Drugs Banned for Use in Food Animals: An Explanation Author(s): Davidson Gigi S
Mar/Apr 2001 Pg. 112-115	From Wagon-Era Paregoric to Computer-Era Herbals Author(s): Newton David W
Mar/Apr 2001 Pg. 140-144	Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing Author(s): Douglass Kate, Kastango Eric S
Nov/Dec 2000 Pg. 474-475	Assignment of a Beyond-Use Date for Compounded Preparations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 261-263	Compounding Using Hazardous Drugs Author(s): Lau Kellie
May/Jun 2000 Pg. 180-181	Compounding OTC Drugs: A Legal Perspective Author(s): Gibbs Jeffrey N, Mazan Kate Duffy
May/Jun 2000 Pg. 186	Pharmacy Licensure Requirements Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 204-205	The Future of Compounding: An Industry Perspective Author(s): Capps Shelly, Winckler Susan C, Anthony Calvin J, Halperin Jerome A
May/Jun 2000 Pg. 222	Assignment of Beyond-Use Dates Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 105-107	Analytical Testing of Extemporaneously Compounded Preparations Author(s): Kupiec Thomas C
Nov/Dec 1999 Pg. 458-459	When Problem Audits Strike Author(s): Heckman H Edward
May/Jun 1999 Pg. 188-191	When is Compounding for Animals Legal? Author(s): Siegner A Wes Jr
Mar/Apr 1999 Pg. 126-127	Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Author(s): Allen Loyd V Jr
Jan/Feb 1999 Pg. 25-29	FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Author(s): Allen Loyd V Jr
Mar/Apr 1998 Pg. 106-108	Opioids for Noncancer Pain: From Controversy to Consensus Author(s): Spanos Alan
Mar/Apr 1998 Pg. 130-133	Firing an Employee - Without Getting Burned Author(s): Davis Jeanie Lerche
Nov/Dec 1997 Pg. 399-403	FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Author(s): Letendre William R
Nov/Dec 1997 Pg. 407	Aspirin in Chloroform (Chloroform Banned in US) Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 71-74	The Decision to Compound Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 73-74	The Compounding Pharmacist Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 75-77	NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies Author(s): Allen Loyd V Jr